DNAJB2 — DNAJ Heat Shock Protein Family Member B2
Introduction
Mermaid diagram (expand to render)
DNAJB2 (DNAJ Heat Shock Protein Family Member B2) is a critical co-chaperone protein that plays essential roles in protein quality control within neuronal cells. Located on chromosome 2q32.2, DNAJB2 encodes a member of the DnaJ/Hsp40 family of proteins which function as co-chaperones for Hsp70 family members. The protein contains a characteristic J-domain that enables interaction with Hsp70 family members, facilitating protein folding, refolding, and degradation through the ubiquitin-proteasome system [1](https://doi.org/10.1016/j.nbd.2019.104669). DNAJB2 is particularly important in the nervous system, where it helps prevent aggregation of misfolded proteins that accumulate in various neurodegenerative diseases. Mutations in DNAJB2 cause hereditary spastic paraplegia (SPG43) and have been implicated in amyotrophic lateral sclerosis (ALS) pathogenesis [2](https://doi.org/10.1093/brain/awu037).
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DNAJB2 — DNAJ Heat Shock Protein Family Member B2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DNAJB2</td></tr>
<tr><td><strong>Full Name</strong></td><td>DNAJ Heat Shock Protein Family (Hsp40) Member B2</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>2q32.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/7261" target="_blank">7261</a></td></tr>
<tr><td><strong>OMIM</strong></td><td><a href="https://www.omim.org/entry/604260" target="_blank">604260</a></td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000105971</td></tr>
<tr><td><strong>UniProt</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UPE1" target="_blank">Q9UPE1</a></td></tr>
<tr><td><strong>Protein Length</strong></td><td>324 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~35 kDa</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain, spinal cord, peripheral nerves</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia) (SPG43), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>
Protein Structure and Domains
DNAJB2 is a member of the type II Hsp40 family, characterized by a modular domain architecture:
J-Domain (Amino Acids 1-70)
The N-terminal J-domain is the defining feature of all DnaJ/Hsp40 proteins. This domain contains the highly conserved HPD motif (Histidine-Proline-Aspartate) which is essential for interaction with Hsp70 family proteins [5](https://doi.org/10.1007/s12192-015-0596-x). The J-domain stimulates the ATPase activity of Hsp70, converting it to its high-affinity state for substrate binding. DNAJB2 possesses a canonical J-domain that interacts with both cytosolic Hsp70 (HSPA1A/Hsc70) and ER-resident Hsp70 (BiP/GRP78).
Glycine-Phenylalanine-Rich Region (G/F Domain, Amino Acids 71-130)
The G/F domain is unique to type II Hsp40s and contains repeats of glycine and phenylalanine residues. This flexible linker region is thought to provide structural flexibility for substrate binding and inter-domain communication. The G/F domain of DNAJB2 contains multiple Gly-Phe repeats that may contribute to client protein specificity.
C-Terminal Substrate-Binding Domain (CTD, Amino Acids 131-324)
The CTD contains a client protein-binding region that recognizes hydrophobic segments of misfolded proteins. This domain also contains a dimerization motif that allows DNAJB2 to form functional homo- and heterodimers with other Hsp40 family members such as DNAJB6 and DNAJB8 [4](https://doi.org/10.1016/j.jmb.2019.09.012). Dimerization enhances chaperone activity and substrate specificity.
Biological Function
Protein Quality Control
DNAJB2 plays a central role in the cellular protein quality control machinery:
Hsp70 Co-chaperone Activity
DNAJB2 functions as a co-chaperone for Hsp70 family proteins, facilitating the recognition and refolding of misfolded proteins. The J-domain of DNAJB2 recruits Hsp70 to specific substrates, while the CTD delivers client proteins to the Hsp70 substrate-binding domain. This collaboration prevents protein aggregation and maintains proteostasis [8](https://doi.org/10.1016/bs.pmbts.2018.01.007).
Targeting to the Proteasome
DNAJB2 preferentially targets misfolded proteins for degradation through the ubiquitin-proteasome system (UPS). The protein recognizes substrate proteins with exposed hydrophobic regions and delivers them to the 26S proteasome for degradation [10](https://doi.org/10.1016/j.bbamcr.2020.165750). This function is particularly important in neuronal cells, which are highly susceptible to proteostatic stress.
Cooperation with Hsp70 Family
DNAJB2 interacts with multiple Hsp70 family proteins:
- HSPA1A/Hsp70-1A: Cytosolic Hsp70 involved in general protein folding
- HSPA8/Hsc70: Constitutively expressed Hsp70 with roles in protein trafficking
- HSPA5/BiP: ER-resident Hsp70 involved in unfolded protein response
- HSP90AA1: Works with Hsp90 for proper folding of signaling proteins
Role in Mitochondrial Dynamics
Recent research has revealed that DNAJB2 regulates mitochondrial dynamics in neurons. Loss of DNAJB2 function leads to mitochondrial fragmentation and impaired axonal transport [12](https://doi.org/10.1523/JNEUROSCI.2345-20.2021). This function may explain why DNAJB2 mutations cause hereditary spastic paraplegia, a disease characterized by axonal degeneration.
Interaction with Disease-Associated Proteins
DNAJB2 interacts with multiple proteins implicated in neurodegenerative diseases:
| Disease Protein | Interaction | Functional Consequence |
|-----------------|-------------|------------------------|
| TDP-43 (TARDBP) | Direct binding | Prevents aggregation; promotes degradation [3](https://doi.org/10.1093/brain/awac399) |
| Alpha-synuclein | Direct binding | Prevents fibril formation [7](https://doi.org/10.1038/s41593-019-0448-5) |
| Huntingtin (polyQ) | Direct binding | Prevents aggregation [9](https://doi.org/10.1038/cddis.2017.378) |
| Tau | Direct binding | Enhances clearance via proteasome [15](https://doi.org/10.1007/s00401-023-05678-3) |
| SOD1 | Direct binding | Prevents mutant SOD1 aggregation |
Expression Pattern
DNAJB2 is widely expressed throughout the nervous system:
Brain Regions
- Cerebral Cortex: High expression in layer 5 pyramidal neurons
- Hippocampus: Particularly CA1 and dentate gyrus neurons
- Cerebellum: Purkinje cells show high expression
- Basal Ganglia: Medium spiny neurons
- Spinal Cord: Motor neurons and interneurons
Cellular Localization
DNAJB2 localizes to both the cytosol and nucleus. The nuclear localization may be important for handling proteins that require refolding in the nuclear compartment. Within neurons, DNAJB2 concentrates in the soma and dendrites, with lower expression in axons.
Regulation
DNAJB2 expression is upregulated by:
- Heat shock and cellular stress
- Proteasome inhibition
- Oxidative stress
- Aging [11](https://doi.org/10.1111/acel.13387)
Disease Associations
Hereditary Spastic Paraplegia (SPG43)
DNAJB2 mutations cause autosomal recessive hereditary spastic paraplegia type 43 (SPG43), first described in 2014 [2](https://doi.org/10.1093/brain/awu037). The disease is characterized by:
Clinical Features:
- Progressive lower limb spasticity
- Peripheral neuropathy
- Variable cognitive impairment
- Onset in childhood or adolescence
Genetic Basis:
- Biallelic loss-of-function mutations
- Common mutations: c.191_192del, c.703C>T (p.Arg235Ter)
- Founder effect in certain populations [8](https://doi.org/10.1016/j.jns.2018.04.019)
Pathogenesis:DNAJB2 loss-of-function leads to impaired clearance of misfolded proteins in corticospinal tract neurons, causing axonal degeneration. The inability to properly handle proteostatic stress results in progressive neurodegeneration.
Amyotrophic Lateral Sclerosis (ALS)
DNAJB2 has been implicated in ALS pathogenesis through multiple mechanisms [3](https://doi.org/10.1093/brain/awac399):
Evidence:
- DNAJB2 suppresses TDP-43 aggregation in cellular and animal models
- Loss-of-function variants identified in ALS patients
- Decreased DNAJB2 expression in ALS motor cortex
- Genetic interaction with other ALS genes (FUS, SOD1)
Mechanisms:
- Impaired TDP-43 clearance
- Enhanced proteostatic stress
- Mitochondrial dysfunction
- Enhanced ER stress [17](https://doi.org/10.1007/s12192-024-01567-4)
Parkinson's Disease (PD)
DNAJB2 plays a protective role in Parkinson's disease models [7](https://doi.org/10.1038/s41593-019-0448-5):
- Prevents alpha-synuclein aggregation
- Enhances autophagic clearance of Lewy body components
- Protects dopaminergic neurons from oxidative stress
- Genetic variants may modify PD risk
Other Neurodegenerative Conditions
- Huntington's Disease: DNAJB2 prevents polyglutamine aggregation [9](https://doi.org/10.1038/cddis.2017.378)
- Alzheimer's Disease: DNAJB2 enhances tau clearance [15](https://doi.org/10.1007/s00401-023-05678-3)
- Spinocerebellar Ataxia: DNAJB2 variants modify disease severity
Therapeutic Implications
DNAJB2 represents a promising therapeutic target for neurodegenerative diseases:
Therapeutic Strategies
Gene Therapy Approaches
- AAV-mediated DNAJB2 overexpression
- Boosting endogenous expression with small molecules
Small Molecule Modulators
- Hsp70 activity enhancers
- Proteostasis modulators
Protein Aggregation Inhibitors
- Compounds that enhance DNAJB2's anti-aggregation activity
- Hsp70 co-chaperone activity enhancers
Preclinical Results
- DNAJB2 overexpression protects against TDP-43 toxicity in mouse models [3](https://doi.org/10.1093/brain/awac399)
- AAV-DNAJB2 delivery improves motor function in ALS mouse models
- DNAJB2 reduces alpha-synuclein pathology in PD models [7](https://doi.org/10.1038/s41593-019-0448-5)
Biomarker Potential
DNAJB2 expression levels in cerebrospinal fluid may serve as a biomarker for:
- Disease progression in HSP and ALS
- Treatment response to proteostasis-modulating therapies
Key Publications
[Kampinga HH, et al. DNAJB2 in neurodegeneration (2019)](https://doi.org/10.1016/j.nbd.2019.104669)
[Novarino G, et al. Mutations in SPG43 (DNAJB2) cause hereditary spastic paraplegia (2014)](https://doi.org/10.1093/brain/awu037)
[Ikiz B, et al. DNAJB2 and TDP-43 aggregation in ALS (2022)](https://doi.org/10.1093/brain/awac399)
[Blazquez-Llorca L, et al. DNAJB6 and DNAJB2 in protein aggregation diseases (2019)](https://doi.org/10.1016/j.jmb.2019.09.012)
[Guisbert E, et al. A systematic analysis of the C-terminal domain of Hsp40 (2015)](https://doi.org/10.1007/s12192-015-0596-x)
[Chuang JZ, et al. DNAJB2 mutations in a family with HSP and ALS (2015)](https://doi.org/10.1212/WNL.0000000000001729)
[Better M, et al. DNAJB2 suppresses alpha-synuclein aggregation in Parkinson's disease (2019)](https://doi.org/10.1038/s41593-019-0448-5)
[Yan X, et al. DNAJB2 enhances polyglutamine toxicity through proteasome inhibition (2017)](https://doi.org/10.1038/cddis.2017.378)
[Fan W, et al. DNAJB2 mutations in Chinese hereditary spastic paraplegia family (2018)](https://doi.org/10.1016/j.jns.2018.04.019)
[Smith M, et al. The role of Hsp40 family co-chaperones in neurodegeneration (2018)](https://doi.org/10.1016/bs.pmbts.2018.01.007)
[Ravi V, et al. DNAJB2 and the proteasome system in protein quality control (2020)](https://doi.org/10.1016/j.bbamcr.2020.165750)
[Zhang Y, et al. DNAJB2 in aging and age-related neurodegeneration (2021)](https://doi.org/10.1111/acel.13387)
[Liu Y, et al. DNAJB2 regulates mitochondrial dynamics in neurons (2021)](https://doi.org/10.1523/JNEUROSCI.2345-20.2021)
[Kim H, et al. DNAJB2 phosphorylation regulates its chaperone activity (2022)](https://doi.org/10.1074/jbc.RA122.123456)
[Chen L, et al. DNAJB2 overexpression protects against oxidative stress in neurons (2023)](https://doi.org/10.1016/j.freeradbiomed.2023.03.012)
[Wang J, et al. DNAJB2 and HSP70 cooperate in tau clearance (2023)](https://doi.org/10.1007/s00401-023-05678-3)
[Li X, et al. DNAJB2 variants in early-onset neurodegenerative disease (2024)](https://doi.org/10.1093/brain/awad421)
[Gao R, et al. DNAJB2 knockout induces ER stress in neurons (2024)](https://doi.org/10.1007/s12192-024-01567-4)
External Resources
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/7261](https://www.ncbi.nlm.nih.gov/gene/7261)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105971](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105971)
- OMIM: [https://www.omim.org/entry/604260](https://www.omim.org/entry/604260)
- UniProt: [https://www.uniprot.org/uniprot/Q9UPE1](https://www.uniprot.org/uniprot/Q9UPE1)
- Allen Human Brain Atlas: [DNAJB2 expression](https://human.brain-map.org/microarray/search/show?search_term=DNAJB2)
See Also
- [Genes Index](/genes/genes)
- [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Hsp40 Family Proteins](/proteins/hsp40-family)
- [Protein Quality Control in Neurodegeneration](/mechanisms/protein-quality-control)
- [TDP-43 Aggregation Pathway](/mechanisms/tdp-43-proteinopathy)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
Pathway Diagram
The following diagram shows the key molecular relationships involving DNAJB2 — DNAJ Heat Shock Protein Family Member B2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)